<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="China and then spread to other countries. Infected persons exhibit" exact="pneumonia" post="indications, progressing to severe acute respiratory disorder. In January"/>
 <result pre="11, 2020, the World Health Organization (WHO) named the Wuhan" exact="pneumonia" post="as Coronavirus Disease-2019 (COVID-19) and declared this infectious disease"/>
 <result pre="the Wuhan pneumonia as Coronavirus Disease-2019 (COVID-19) and declared this" exact="infectious disease" post="to be a global pandemic. Certain animals, including mammals,"/>
 <result pre="Certain animals, including mammals, reptiles, and birds prone to this" exact="infectious disease" post="caused by the virus are deadly, while there have"/>
 <result pre="documented as potential approved drug targets for several infections, including" exact="hepatitis" post="C virus (HCV) and human immunodeficiency virus (HIV) [3]."/>
 <result pre="have already mentioned the role of T. crispa extracts against" exact="malaria" post="and the recent successful usage of anti-malarial drugs in"/>
 <result pre="combat cardiovascular diseaseCurr. Med. Chem.2012192242225110.2174/09298671280022907822414106 43.LeeK.W.BodeA.M.DongZ.Molecular targets of phytochemicals for" exact="cancer" post="preventionNat. Rev. Cancer20111121121810.1038/nrc301721326325 44.SinghR.ArifT.KhanI.SharmaP.Phytochemicals in antidiabetic drug discoveryJ. Biomed."/>
 <result pre="Tacca integrifolia rhizome and investigation of possible lead compounds against" exact="breast cancer" post="through in silico approachesClin. Phytosci.201953610.1186/s40816-019-0127-x 52.BrooijmansN.KuntzI.D.Molecular recognition and docking"/>
 <result pre="integrifolia rhizome and investigation of possible lead compounds against breast" exact="cancer" post="through in silico approachesClin. Phytosci.201953610.1186/s40816-019-0127-x 52.BrooijmansN.KuntzI.D.Molecular recognition and docking"/>
 <result pre="Biomol. Struct.20033233537310.1146/annurev.biophys.32.110601.14253212574069 53.RakibA.SamiS.A.MimiN.J.ChowdhuryM.M.EvaT.A.NainuF.PaulA.ShahriarA.TareqA.M.EmonN.U.et al.Immunoinformatics-guided design of an epitope-based vaccine against" exact="severe acute respiratory syndrome" post="coronavirus 2 spike glycoproteinComput. Biol. Med.202012410396710.1016/j.compbiomed.2020.10396732828069 54.YamamotoN.MatsuyamaS.HoshinoT.YamamotoN.Nelfinavir inhibits replication"/>
 <result pre="coronavirus 2 spike glycoproteinComput. Biol. Med.202012410396710.1016/j.compbiomed.2020.10396732828069 54.YamamotoN.MatsuyamaS.HoshinoT.YamamotoN.Nelfinavir inhibits replication of" exact="severe acute respiratory syndrome" post="coronavirus 2 in vitroBioRxiv202010.1101/2020.04.06.026476 55.YamamotoN.YangR.YoshinakaY.AmariS.NakanoT.CinatlJ.RabenauH.DoerrH.W.HunsmannG.OtakaA.et al.HIV protease inhibitor nelfinavir"/>
 <result pre="Res. Commun.200431871972510.1016/j.bbrc.2004.04.08315144898 56.KangC.K.SeongM.-W.ChoiS.-J.KimT.S.ChoeP.G.SongS.H.KimN.-J.ParkW.B.OhM.In vitro activity of lopinavir/ritonavir and hydroxychloroquine against" exact="severe acute respiratory syndrome" post="coronavirus 2 at concentrations achievable by usual dosesKorean J."/>
</results>
